Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation
about
sameAs
Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimatesHeparin versus placebo for non-ST elevation acute coronary syndromesAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesRisks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic ReviewGastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatmentFondaparinux in the management of patients with ST-elevation acute myocardial infarctionArgatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation.Perspectives on the management of coronary artery disease in India.Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.Efficacy and safety of fondaparinux in patients with acute coronary syndromes.Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes.New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implicationsContemporary therapy of acute ST-elevation myocardial infarction.Acute coronary syndromes: Diagnosis and management, part II.Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial Infarction.Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.Adding clopidogrel to aspirin improves outcome in ST-elevation myocardial infarction patients receiving fibrinolytic therapy.Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?
P2860
Q24186056-655952B6-962B-426B-B304-4DBBF86A57BDQ24193744-C735B833-E0F7-4256-A37C-D46F3C721CA0Q24633053-D7CD9EBD-D504-4135-A82F-43A65CB34C63Q27026079-CAE2A04E-A665-4596-B9A2-279259799DD0Q27027977-BD39BDC0-3B5D-4CED-9571-18EBEEA6614DQ28219415-36C393B2-32E9-4998-9026-922D64F9DC59Q33369690-C006F98F-B305-42A3-90A0-87AF771C96FEQ33632559-581CF004-2AEE-4753-9E46-15C0D3679C29Q36057242-917FE3B5-FF89-471C-8D69-EAC5F6F47B25Q36545687-A0875422-6326-4C4C-B2E0-1FFA8BC8A720Q37012898-F121D697-3814-42CF-B143-0B201B206F5AQ37175915-3C6C5C16-A061-46E9-8EE0-3D5DD2535724Q37193906-2C510C0D-372F-4C24-A37B-4973370F39BFQ37287692-A4D8125C-6561-4DFE-BEDA-BA6ED3AFE356Q37406719-AA43A2D7-E27E-4ED0-8D86-41F2801B0EABQ37414802-1E570293-C414-4111-913B-B90F35994163Q40783276-1376B267-8DDD-4324-AE2E-4F313B66111AQ43266392-A2A97C31-A118-4204-B163-875306EADE5DQ46040626-50095024-FC6F-4651-8F3C-DC11A8B2447CQ46083556-2B94AEAB-A59A-4798-A135-5E013E444E36Q47336065-3662111E-33CB-4C5B-B193-C3DFBDCB2207
P2860
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@ast
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@en
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@nl
type
label
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@ast
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@en
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@nl
prefLabel
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@ast
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@en
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@nl
P2093
P356
P1476
Effects of reviparin, a low-mo ...... ting with ST-segment elevation
@en
P2093
Changchun Xie
Denis Xavier
Lisheng Liu
Rashid J Ahmed
Shamir R Mehta
P304
P356
10.1001/JAMA.293.4.427
P407
P50
P577
2005-01-26T00:00:00Z